BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/26/2021 7:48:01 AM | Browse: 561 | Download: 1094
 |
Received |
|
2021-02-13 22:16 |
|
Peer-Review Started |
|
2021-02-13 22:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-17 01:07 |
|
Revised |
|
2021-03-31 11:36 |
|
Second Decision |
|
2021-05-08 08:08 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-05-08 08:55 |
|
Articles in Press |
|
2021-05-08 08:55 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-05-27 17:58 |
|
Typeset the Manuscript |
|
2021-06-23 13:28 |
|
Publish the Manuscript Online |
|
2021-06-26 07:48 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Immunotherapy in the treatment of lymphoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Lazar S Popovic, Gorana Matovina-Brko, Maja Popovic, Milica Popovic, Ana Cvetanovic, Ivan Nikolic, Biljana Kukic and Dragana Petrovic |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Lazar S Popovic, MD, PhD, Professor, Department for Medical Oncology, Oncology Institute of Vojvodina, University of Novi Sad, Put dr Goldmana 4, Novi Sad 21000, Serbia. lazar.popovic@yahoo.com |
| Key Words |
Immunotherapy; Receptors; Chimeric antigen; Antibodies; Monoclonal; Immunoconjugates; Hodgkin disease; Lymphoma; Large B-cell; Diffuse |
| Core Tip |
Relapsed or refractory non-Hodgkin’s lymphomas, especially diffuse large B-cell lymphoma, are hard-to-treat diseases. Many immunotherapeutic options have changedthe course of treatment for different solid tumors. Here, we discuss the results, positions, practical aspects and future directions of different drugs and cellular therapies for the treatment of lymphoma. |
| Publish Date |
2021-06-26 07:48 |
| Citation |
Popovic LS, Matovina-Brko G, Popovic M, Popovic M, Cvetanovic A, Nikolic I, Kukic B, Petrovic D. Immunotherapy in the treatment of lymphoma. World J Stem Cells 2021; 13(6): 503-520 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i6/503.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i6.503 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
